Your browser doesn't support javascript.
loading
[Total polyphenols of Cydonia oblonga inhibited proliferation and migration of renal cancer cells by PI3K/Akt/mTOR pathway].
Abudurousuli, Kayisaier; Han, Meng-Yuan; Hailati, Sendaer; Maihemuti, Nulibiya; Talihati, Ziruo; Nueraihemaiti, Nuerbiye; Dilimulati, Dilihuma; Baishan, Alehaer; Aikebaier, Alifeiye; Zhou, Wen-Ting.
Afiliación
  • Abudurousuli K; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Han MY; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Hailati S; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Maihemuti N; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Talihati Z; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Nueraihemaiti N; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Dilimulati D; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Baishan A; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Aikebaier A; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
  • Zhou WT; School of Pharmacy, Xinjiang Medical University, Xinjiang Key Laboratory of Active Components and Drug Release Technology of Natural Medicines Urumqi 830017, China.
Zhongguo Zhong Yao Za Zhi ; 49(4): 1052-1063, 2024 Feb.
Article en Zh | MEDLINE | ID: mdl-38621912
ABSTRACT
The mechanism of total polyphenols of Cydonia oblonga Miller(TPCOM) against kidney cancer was elucidated through a combination of network pharmacology, bioinformatics, and experimental verification. The active polyphenolic compounds from C. oblonga were screened by network pharmacological techniques and kidney cancer-related targets were collected through the database. The differential gene expression analysis was performed on RNA sequencing data from tumor tissue and normal tissue of kidney cancer patients obtained from the Gene Expression Omnibus(GEO) database. The results of network pharmacology predictions and differential gene expression analysis were used to identify the core genes targeted by TPCOM in kidney cancer. Survival analysis was conducted to identify key targets that could impact patient survival, followed by Kyoto Encyclopedia of Genes and Genomes(KEGG) and Gene Ontology(GO) enrichment analyses. Cell proliferation and activity experiments(cell counting kit-8) were conducted using TPCOM at concentrations ranging from 20 to 640 µg·mL~(-1) on 786-O and Renca cells. Additionally, TPCOM at concentrations of 40, 80, and 160 µg·mL~(-1) was applied to kidney cancer cells to assess its effect on cell migration and its regulation of protein expression levels related to the protein kinase B(Akt), mammalian target of rapamycin(mTOR), and phosphoinositide 3-kinase(PI3K) signaling pathways. Network pharmacology predicted eight active polyphenolic compounds from C. oblonga. Survival analysis revealed 15 significantly differentially expressed genes in kidney cancer that were affected by TPCOM and had a significant impact on patient survival. KEGG and GO analysis results indicated that these 15 targets were primarily associated with the PI3K/Akt signaling pathway, cell migration, and proliferation. The results showed that TPCOM could inhibit the proliferation of 786-O and Renca cells, with IC_(50) values of 121.4 and 137.9 µg·mL~(-1), respectively. TPCOM was also found to inhibit the migration of these cells and suppress the PI3K/Akt/mTOR signaling pathway. TPCOM may exert its anti-kidney cancer effects by inhibiting the activation of the PI3K/Akt/mTOR signaling pathway, thereby restraining the proliferation and migration of kidney cancer cells. This study provides a foundation for the research on the anti-tumor effects of natural product C. oblonga, particularly in Xinjiang, and holds significance for further promoting its development and utilization.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: China